1. Yiqi Jiedu herbal decoction attenuates the 2 Gy 60Co γ ray induced spleen injury by inhibiting apoptosis and modulating the immune balance
   An Wang et al, 2022, Journal of Ethnopharmacology CrossRef
2. Looking Beyond Th17 Cells: A Role for Th17.1 Cells in Thyroid-associated Ophthalmopathy?
   Minmin Jiang et al, 2023, Endocrinology CrossRef
3. Teprotumumab versus intravenous methylprednisolone in thyroid eye disease: A systematic review
   Faizan Mehmood et al, 2024, Oman Journal of Ophthalmology CrossRef
4. Graves' ophthalmopathy and dry eye syndrome
   Edoardo APPOLLONI et al, 2023, Minerva Ophthalmology CrossRef
5. Efficacy and Safety of 6-Weekly versus 12-Weekly Intravenous Methylprednisolone in Moderate-to-Severe Active Thyroid-Associated Ophthalmopathy
   Kenneth K. H. Lai et al, 2023, Journal of Clinical Medicine CrossRef
6. Identification of potential immunotherapeutic targets and prognostic biomarkers in Graves' disease using weighted gene co-expression network analysis
   Nianrong Mi et al, 2024, Heliyon CrossRef
7. Ocular surface disease in thyroid eye disease: A narrative review
   Harkaran S. Rana et al, 2022, The Ocular Surface CrossRef
8. A comprehensive epigenetic network can influence the occurrence of thyroid-associated ophthalmopathy by affecting immune and inflammatory response
   Zhuo Zhang et al, 2024, Scientific Reports CrossRef
9. Immunophenotype of Lacrimal Glands in Graves Orbitopathy: Implications for the Pathogenesis of Th1 and Th17 Immunity
   Yazhuo Huang et al, 2022, Thyroid CrossRef
10. Comparison of the efficacy of two different glucocorticoid regimens for treatment of active moderate-to-severe Graves’ orbitopathy
    Mariya Asenova Stoynova et al, 2023, International Ophthalmology CrossRef
11. Effectiveness of Different Treatment Modalities in Initial and Chronic Phases of Thyroid Eye Disease: A Systematic Review With Meta-analysis
    Jose Mario Alves Junior et al, 2024, The Journal of Clinical Endocrinology & Metabolism CrossRef
12. A Randomized Clinical Trial of Intravenous Methylprednisolone With 2 Protocols in Patients With Graves Orbitopathy
    Zhangfang Li et al, 2023, The Journal of Clinical Endocrinology & Metabolism CrossRef
13. Network Meta-Analysis of Different Intravenous Glucocorticoid Regimes for the Treatment of Graves’ Orbitopathy
    Jun Jia et al, 2022, Frontiers in Pharmacology CrossRef